Why the Nanosonics Ltd. share price is going nuts today

Nanosonics Ltd. (ASX:NAN) shares have started the week with a bang following the release of its latest quarterly update. Is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The shares of infection control specialist Nanosonics Ltd. (ASX: NAN) have been an early mover this week. In morning trade its shares have climbed 5.5% to $3.10 after the release of an impressive quarterly update.

That update revealed that sales in the quarter ending 31 December 2016 came in at a record $18.3 million, bringing half-year sales to $36.1 million. This meant that sales in the half grew a massive 131% on the prior corresponding period.

Pleasingly Nanosonics was cash flow positive for a fourth consecutive quarter. Cash on hand increased by $3.3 million to $56.9 million by the end of the quarter.

The lucrative North American market has yet again been key to this explosive growth. Its environmentally friendly ultrasound probe disinfection system saw its installed base in the market grow by 60% to 10,700 units.

But it's not just North America providing growth. The company has made progress in the United Kingdom as well. Six of the 14 Scottish NHS trusts have commenced the adoption of its technology since new guidelines in Scotland were announced. Overall the company's global installed base now totals approximately 12,300 units.

I can't say I'm surprised by this growth. The company's trophon EPR system is wholly effective at disinfecting ultrasound probes, whereas current toxic disinfectants being used are largely ineffective. I believe this gives it a competitive advantage in this small, but lucrative market.

Although at 51x estimated FY 2017's earnings its shares do look a little on the expensive side compared to other healthcare shares such as CSL Limited (ASX: CSL), I believe that there is still significant growth potential in North America and Europe that justifies the premium.

I feel Nanosonics would be a great long-term buy and hold investment, although due to the premium its shares trade at I would suggest investors restrict it to just a small part of their portfolio.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »